Avalon GloboCare Corp (NASDAQ:AVCO) CEO Dr David Jin joins Proactive's Stephen Gunnion with details of a 'transformative' deal worth $31 million to acquire a 60% stake in Laboratory Services MSO and expand its focus on lab testing and services.
Jin tells Proactive that California-headquartered Laboratory Services has completed over 600,000 tests since inception and will add strong clinical synergies to the existing Avalon portfolio.
As part of the deal, shares in Avalon will begin trading under a new ticker symbol 'ALBT' on the Nasdaq on November 10, he adds.